Serum IL 26 as a Marker of Disease Activity in SLE
NCT05161988 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2021-12-17
Summary
Assessment of serum Interleukin 26 level in SLE patients and compare it with healthy controls.
Association of serum interleukin 26 with SLE activity and severity.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 15 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-10
- Primary Completion
- 2024-12-01
- Completion
- 2025-05-01
More Related Trials
-
Assessment of Blood Indices in Systemic Lupus Erythematosus
NCT06872086 ·Status: NOT_YET_RECRUITING
-
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
NCT06063668 ·Status: NOT_YET_RECRUITING
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus
NCT05179018 ·Status: UNKNOWN
-
Evaluation Of Serum MIF Level in SLE Patients
NCT05253638 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Type I IFN Level and Disease Activity in SLE Patients
NCT05446428 ·Status: UNKNOWN
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Improving the Assessment of SLE Disease Activity
NCT03144063 ·Status: COMPLETED
-
Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients
NCT05105217 ·Status: UNKNOWN
-
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage
NCT05045417 ·Status: UNKNOWN
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
The Role of Lipids in Immune Cell Function in SLE Patients
NCT04361734 ·Status: UNKNOWN
-
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
NCT01992666 ·Status: COMPLETED ·Phase: NA
-
Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus
NCT05900232 ·Status: UNKNOWN ·Phase: NA
-
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity
NCT05106998 ·Status: UNKNOWN
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE
NCT06698900 ·Status: COMPLETED
-
Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment
NCT04256577 ·Status: UNKNOWN
-
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus Erythematosus
NCT05724940 ·Status: UNKNOWN
-
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
NCT06151990 ·Status: RECRUITING
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Efficacy and Safety of Belimumab in SLE Patients
NCT04515719 ·Status: COMPLETED ·Phase: PHASE4
-
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
NCT06610422 ·Status: NOT_YET_RECRUITING
-
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage
NCT04558814 ·Status: UNKNOWN ·Phase: NA
-
Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care Unit
NCT05418855 ·Status: UNKNOWN